Search
Menu
Home
HTB
2018
April
April 2018
Contents
Editorial
16 April 2018: vol 19 no 7: CROI 2018 part 3
In memory
In Memory: Professor David Cooper
Conference reports
CROI 2018: third reports
No increased risk of IRIS in people with low CD4 counts receiving raltegravir in the REALITY trial
Isoniazid preventive TB therapy in pregnancy and postpartum: recommendations now need to be re-evaluated
Efavirenz might decrease effectiveness of the vaginal contraceptive ring
Switch to TAF appears safe and effective in adolescents: similar PK to adults
Doubling raltegravir dose could overcome interaction with rifampicin in children aged 2 to 6
Twice-daily bictegravir does not overcome drug interaction with rifampicin
Reducing risk of myocardial infarction (MI) in HIV positive people
M184V mutation associated with increased risk of viral blip but not viral failure with 3TC-based dual therapy
HIV prevention and transmission
PrEP engagement workshops
On the web
Legal Aide – an app if arrested for personal drug possession
IAS reviews
TAGline Spring 2018
PDFs
16 April 2018: vol 19 no 7
HTB RSS
Early access
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
HIV organisations support trans and non-binary communities against the unworkable EHRC guidelines
30 June 2025
Long-acting injectable PrEP approved in the US: priced at $28,000 a year
28 June 2025
Clinical studies of two once-weekly pipeline compounds put on hold
27 June 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Kigala Call to Action: sign-on for IAS 2025 conference
1 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate